Socioeconomic gradients in tiotropium use among adults with COPD

Socioeconomic gradients in tiotropium use among adults with COPD

Paul D Blanc1,2,3, Mark D Eisner1,2, Edward H Yelin4,5, Gillian Earnest1, John R Balmes1,2, Steven E Gregorich6, Patricia P Katz4,51Division of Occupational and Environmental Medicine, 2Division of Pulmonary and Critical Care Medicine, 4Division of Rheumatology, 6Division of General Internal Medicin...

Full description

Bibliographic Details
Main Authors:	Paul D Blanc, Mark D Eisner, Edward H Yelin, Gillian Earnest, John R Balmes, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-10-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/socioeconomic-gradients-in-tiotropium-use-among-adults-with-copd-a2463

Similar Items

Work life of persons with asthma, rhinitis, and COPD: A study using a national, population-based sample
by: Earnest Gillian, et al.
Published: (2006-02-01)

Directly measured secondhand smoke exposure and COPD health outcomes
by: Balmes John, et al.
Published: (2006-06-01)

Effect of add-on therapy of tiotropium in COPD treated with theophylline
by: Tomotaka Kawayama, et al.
Published: (2008-03-01)

The impact of SHS exposure on health status and exacerbations among patients with COPD
by: Mark D Eisner, et al.
Published: (2009-05-01)

Efficacy of tiotropium in the prevention of exacerbations of COPD
by: Antonio Anzueto, et al.
Published: (2009-06-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Tiotropium HandiHaler&reg; in the treatment of COPD: A safety review
by: Steven Kesten, et al.
Published: (2009-10-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
by: Ichinose M, et al.
Published: (2018-07-01)

Tiotropium in COPD: clinical outcomes and economic evidence
by: Orietta Zaniolo, et al.
Published: (2010-03-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
by: Ichinose M, et al.
Published: (2018-10-01)

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD
by: A-B Tonnel, et al.
Published: (2008-06-01)

Safety, tolerability and risk benefit analysis of tiotropium in COPD
by: Yuji Oba, et al.
Published: (2008-11-01)

The effect of tiotropium therapy on markers of elastin degradation in COPD
by: Tartell Lori, et al.
Published: (2009-02-01)

Efficacy and safety of tiotropium Respimat&reg; SMI in COPD in two 1-year randomized studies
by: Eric Bateman, et al.
Published: (2010-06-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
by: Derom E, et al.
Published: (2016-12-01)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
by: Pelaia G, et al.
Published: (2015-10-01)

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations
by: Kai-Michael Beeh, et al.
Published: (2009-02-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance
by: Nicolino Ambrosino, et al.
Published: (2008-10-01)

COPD patients responding to Tiotropium with dyspnea relief: a proof of efficacy?
by: Rossi, Stephanie
Published: (2009)

Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
by: Balmes John, et al.
Published: (2005-05-01)

Body composition and functional limitation in COPD
by: Katz Patricia P, et al.
Published: (2007-01-01)

Preventing and managing exacerbations in COPD &ndash; critical appraisal of the role of tiotropium
by: Donald P Tashkin
Published: (2010-02-01)

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
by: Cristoforo Incorvaia, et al.
Published: (2008-03-01)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
by: Covelli H, et al.
Published: (2015-12-01)

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis
by: Marc Miravitlles, et al.
Published: (2017-11-01)

Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity
by: Eisner Mark D, et al.
Published: (2000-12-01)

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
by: Owen Roger, et al.
Published: (2010-10-01)

Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients
by: Miravitlles M, et al.
Published: (2016-01-01)

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
by: Anzueto AR, et al.
Published: (2017-05-01)

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study
by: Sauer R, et al.
Published: (2016-04-01)

Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
by: Chenglong Li, et al.
Published: (2019-02-01)

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
by: Trudo F, et al.
Published: (2015-09-01)

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis
by: Halpin DMG, et al.
Published: (2015-02-01)

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
by: Valipour A, et al.
Published: (2019-10-01)

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients
by: Steven Kesten, et al.
Published: (2008-03-01)

Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation
by: Orietta Zaniolo, et al.
Published: (2011-06-01)

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
by: Koehorst-ter Huurne K, et al.
Published: (2018-05-01)

Cannot write session to /tmp/vufind_sessions/sess_vf9j8jfus71bsmah3tceeblr45